Abstract: The activity of the enzyme aromatase is inhibited by administering an aromatase inhibiting amount of a composition comprising at least one of astaxanthin, black cohosh, echinacea, and phytosterols to a subject.

Abstract: Compositions for the treatment of acne have an active ingredient in an amount sufficient to inhibit the growth of Propionibacterium acnes and, optionally, at least one inactive ingredient, where the active ingredient is selected from the group consisting of green tea extract, grape seed extract, cranberry extract, and mixtures thereof. The compositions may be substantially free of skin-irritating materials.

Abstract: Compositions for the treatment of acne have an active ingredient in an amount sufficient to inhibit the growth of Propionibacterium acnes and, optionally, at least one inactive ingredient, where the active ingredient is selected from the group consisting of green tea extract, grape seed extract, cranberry extract, and mixtures thereof. The compositions may be substantially free of skin-irritating materials.

Abstract: The activity of the enzyme aromatase is inhibited by administering an aromatase inhibiting amount of a composition comprising at least one of astaxanthin, black cohosh, echinacea, and phytosterols to a subject.

Abstract: Echinacea dietary supplements are useful adjuvants for live anticoccidial vaccines. Feed supplementation with Echinacea preparations enhances the immune response to such vaccines. Echinacea purpurea in amounts of about 0.1% to 0.5% administered for about two weeks to day-old chicks has been found effective for providing significant weight gain compared to vaccination alone.

Abstract: A chromium(III)-containing carbohydrase enzyme food supplement composition providing at least one cellulase fungal enzyme, at least one alpha amylase fungal enzyme, at least one hemicellulase fungal enzyme, at least on chromium(III) compound, and, optionally, at least one acceptable carrier.

Abstract: A method for inhibiting the activity of the enzyme 5&agr;-reductase in a human subject is provided which comprises administering to the subject a composition comprising the carotenoid astaxanthin. Administration of the composition to inhibit the enzyme is useful to prevent and treat benign prostate hyperplasia (BPH) and prostate cancer in human males.

Abstract: This invention relates to a method of increasing the yield of extractable substance from a botanical in the gastrointestinal system of a human being comprising the step of ingesting an enzyme composition comprising a cellulase enzyme and a pectinase enzyme at approximately the same time as a botanical is ingested so that the cellulase and pectinase enzymes degrade the cellulosic and pectin constituents, respectively, contained in the ingested botanical, to obtain an enhanced quantity of extractable substance from the botanical. Another method of use embodiment of this invention comprises the step of ingesting an enzyme composition comprising a cellulase enzyme, a pectinase enzyme, a hemicellulase enzyme and a xylanase enzyme at approximately the same time as a botanical is ingested, to obtain an enhanced quantity of extractable substance from the botanical.

Abstract: This invention relates to a beta-fructofuranosidase enzyme food supplement composition, which alleviates gastrointestinal distress caused by ingested food containing oligosaccharides, comprising a beta-fructofuranosidase enzyme, a cellulase enzyme and a hemicellulase enzyme. This invention also relates to a method of alleviating gastrointestinal distress in the gastrointestinal system of a human being, which distress is caused by ingested food containing oligosaccharides, the method comprising the step of ingesting a beta-fructofuranosidase enzyme, to convert oligosaccharides contained in the ingested food to reducing sugars.

Abstract: This invention relates to a beta-fructofuranosidase enzyme food supplement composition, which alleviates gastrointestinal distress caused by ingested food containing oligosaccharides, comprising a beta-fructofuranosidase enzyme, a cellulase enzyme and a hemicellulase enzyme. More particularly, the enzyme food supplement composition of this invention comprises a beta-fructofuranosidase enzyme, a cellulase enzyme, a hemicellulase enzyme, a lipase enzyme and an acid protease enzyme. This invention also relates to a method of alleviating gastrointestinal distress in the gastrointestinal system of a human being, which distress is caused by ingested food containing oligosaccharides, the method comprising the step of ingesting a beta-fructofuranosidase enzyme food supplement composition comprising a beta-fructofuranosidase enzyme, a cellulase enzyme and a hemicellulase enzyme, to convert oligosaccharides contained in the ingested food to reducing sugars.

Abstract: This invention relates to a beta-fructofuranosidase enzyme food supplement composition, which alleviates gastrointestinal distress caused by ingested food containing oligosaccharides, comprising a beta-fructofuranosidase enzyme, a cellulase enzyme and a hemicellulase enzyme. More particularly, the enzyme food supplement composition of this invention comprises a beta-fructofuranosidase enzyme, a cellulase enzyme, a hemicellulase enzyme, a lipase enzyme and an acid protease enzyme. This invention also relates to a method of alleviating gastrointestinal distress in the gastrointestinal system of a human being, which distress is caused by ingested food containing oligosaccharides, the method comprising the step of ingesting a beta-fructofuranosidase enzyme food supplement composition comprising a beta-fructofuranosidase enzyme, a cellulase enzyme and a hemicellulase enzyme, to convert oligosaccharides contained in the ingested food to reducing sugars.

Abstract: This invention relates to a proteolytic fungal enzyme food supplement composition comprising a unique combination of at least one acid protease fungal enzyme and at least one semi-alkaline protease fungal enzyme. More particularly, the invention relates to a proteolytic fungal food supplement composition comprising a unique combination of an acid protease fungal enzyme obtained from Rhizopus niveus or Aspergillus niger var. macrosporus and a semi-alkaline protease fungal enzyme obtained from Aspergillus oryzae or any species of Rhizopus including Rhizopus niveus and Rhizopus oryzae, wherein the acid protease fungal enzyme is present in an amount of at least 50 SAP and the semi-alkaline protease fungal enzyme is present in an amount of at least 25,000 HUT, the amounts being per gram of composition.